IL6 and lung carcinoma: Compared to the sham group, the expression of IL‐6, phosphorylated STAT3 and two major MAPKs subtypes (phosphorylated p38‐MAPK and phosphorylated ERK1/2) were significantly increased in the lung cancer model group (Figure 6B).